108 related articles for article (PubMed ID: 31792675)
1. A novel RNA sequencing-based risk score model to predict papillary thyroid carcinoma recurrence.
He J; Tian Z; Yao X; Yao B; Liu Y; Yang J
Clin Exp Metastasis; 2020 Apr; 37(2):257-267. PubMed ID: 31792675
[TBL] [Abstract][Full Text] [Related]
2. Identification of a Signature Comprising 5 Soluble Carrier Family Genes to Predict the Recurrence of Papillary Thyroid Carcinoma.
Han R; Sun W; Zhang H
Technol Cancer Res Treat; 2021; 20():15330338211036314. PubMed ID: 34590520
[TBL] [Abstract][Full Text] [Related]
3. Single-cell and bulk RNA sequencing reveal heterogeneity and diagnostic markers in papillary thyroid carcinoma lymph-node metastasis.
Lu DN; Zhang WC; Lin YZ; Jiang HY; He R; Li SL; Zhang YN; Shao CY; Zheng CM; Xu JJ; Ge MH
J Endocrinol Invest; 2024 Jun; 47(6):1513-1530. PubMed ID: 38146045
[TBL] [Abstract][Full Text] [Related]
4. Young and resilient: Unraveling papillary thyroid cancer outcomes in males under 40.
Hood C; Zmijewski PV; McLeod MC; Herring B; Bahl D; Fazendin J; Lindeman B; Chen H; Gillis A
World J Surg; 2024 May; 48(5):1190-1197. PubMed ID: 38517350
[TBL] [Abstract][Full Text] [Related]
5. Integrated analysis of tumor microenvironment features to establish a diagnostic model for papillary thyroid cancer using bulk and single-cell RNA sequencing technology.
Wang Y; Song W; Li Y; Liu Z; Zhao K; Jia L; Wang X; Jiang R; Tian Y; He X
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16837-16850. PubMed ID: 37733241
[TBL] [Abstract][Full Text] [Related]
6. A novel risk stratification model based on tumor size and multifocality to predict recurrence in pediatric PTC: comparison with adult PTC.
Du R; Zhang Y; Kou J; Li J; Sui C; Zhang D; Fu Y; Zhou L; Fu Q; Li F; Dionigi G; Liang N; Sun H
Front Endocrinol (Lausanne); 2023; 14():1298036. PubMed ID: 38274235
[TBL] [Abstract][Full Text] [Related]
7. The Updated AJCC/TNM Staging System for Papillary Thyroid Cancer (8th Edition): From the Perspective of Genomic Analysis.
Kim K; Kim JH; Park IS; Rho YS; Kwon GH; Lee DJ
World J Surg; 2018 Nov; 42(11):3624-3631. PubMed ID: 29750323
[TBL] [Abstract][Full Text] [Related]
8. Risk factors and predictive model for recurrence in papillary thyroid carcinoma: a single-center retrospective cohort study based on 955 cases.
Li Y; Tian J; Jiang K; Wang Z; Gao S; Wei K; Yang A; Li Q
Front Endocrinol (Lausanne); 2023; 14():1268282. PubMed ID: 37810888
[TBL] [Abstract][Full Text] [Related]
9. Impact of Additional Preoperative Computed Tomography Imaging on Staging, Surgery, and Postsurgical Survival in Patients With Papillary Thyroid Carcinoma.
Jeong SY; Chung SR; Baek JH; Choi YJ; Kim S; Sung TY; Song DE; Kim TY; Lee JH
Korean J Radiol; 2023 Dec; 24(12):1284-1292. PubMed ID: 38016686
[TBL] [Abstract][Full Text] [Related]
10. A diagnostic model based on DNA methylation haplotype block characteristics for identifying papillary thyroid carcinoma from thyroid adenoma.
Xu D; Lai Y; Liu H; Li H; Feng N; Liu Y; Gong C; Zhang Y; Zhou J; Shen Y
Transl Res; 2024 Feb; 264():76-84. PubMed ID: 37863284
[TBL] [Abstract][Full Text] [Related]
11. Chromatin accessibility associates with protein-RNA correlation in human cancer.
Sanghi A; Gruber JJ; Metwally A; Jiang L; Reynolds W; Sunwoo J; Orloff L; Chang HY; Kasowski M; Snyder MP
Nat Commun; 2021 Sep; 12(1):5732. PubMed ID: 34593797
[TBL] [Abstract][Full Text] [Related]
12. Construction of a Signature Model to Predict the Radioactive Iodine Response of Papillary Thyroid Cancer.
Liu L; Shi Y; Lai Q; Huang Y; Jiang X; Liu Q; Huang Y; Xia Y; Xu D; Jiang Z; Tu W
Front Endocrinol (Lausanne); 2022; 13():865909. PubMed ID: 35634509
[TBL] [Abstract][Full Text] [Related]
13. Prognostic prediction of patients having classical papillary thyroid carcinoma with a 4 mRNA-based risk model.
Xiang L; Zhao JH; Tang Y; Tan JW; Li LB; Gong C
Medicine (Baltimore); 2024 Jun; 103(23):e38472. PubMed ID: 38847736
[TBL] [Abstract][Full Text] [Related]
14. Spatial transcriptomics reveals prognosis-associated cellular heterogeneity in the papillary thyroid carcinoma microenvironment.
Yan K; Liu QZ; Huang RR; Jiang YH; Bian ZH; Li SJ; Li L; Shen F; Tsuneyama K; Zhang QL; Lian ZX; Guan H; Xu B
Clin Transl Med; 2024 Mar; 14(3):e1594. PubMed ID: 38426403
[TBL] [Abstract][Full Text] [Related]
15. Identification and validation of a prognostic anoikis-related gene signature in papillary thyroid carcinoma by integrated analysis of single-cell and bulk RNA-sequencing.
Zheng K; Zhang XX; Yu X; Yu B; Yang YF
Medicine (Baltimore); 2024 May; 103(19):e38144. PubMed ID: 38728457
[TBL] [Abstract][Full Text] [Related]
16. Identification and validation of an anoikis-related genes signature for prognostic implication in papillary thyroid cancer.
Zhao R; Lu Y; Wan Z; Qiao P; Yang L; Zhang Y; Huang S; Chen X
Aging (Albany NY); 2024 Apr; 16(8):7405-7425. PubMed ID: 38663918
[TBL] [Abstract][Full Text] [Related]
17. Interactions between LAMP3+ dendritic cells and T-cell subpopulations promote immune evasion in papillary thyroid carcinoma.
Wang Z; Ji X; Zhang Y; Yang F; Su H; Zhang H; Li Z; Zhang W; Sun W
J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38816233
[TBL] [Abstract][Full Text] [Related]
18. Thyroid papillary carcinoma combined with primary follicular lymphoma: a case report.
Xu T; Wu L; Ye H; Luo S; Wang J
Diagn Pathol; 2024 May; 19(1):69. PubMed ID: 38773600
[TBL] [Abstract][Full Text] [Related]
19. Network medicine approaches for identification of novel prognostic systems biomarkers and drug candidates for papillary thyroid carcinoma.
Kori M; Temiz K; Gov E
J Cell Mol Med; 2023 Dec; 27(24):4171-4180. PubMed ID: 37859510
[TBL] [Abstract][Full Text] [Related]
20. Transcriptomic signature associated with carcinogenesis and aggressiveness of papillary thyroid carcinoma.
Teng H; Mao F; Liang J; Xue M; Wei W; Li X; Zhang K; Feng D; Liu B; Sun Z
Theranostics; 2018; 8(16):4345-4358. PubMed ID: 30214625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]